RemSleep Holdings (RMSL) EBIT Margin Growth (1y) (2023 - 2025)

RemSleep Holdings (RMSL) EBIT Margin Growth (1y) (2023 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Abbott Laboratories 157.80 Bn 151.14 Bn 6.27 Bn -430.00
2 Stryker 115.54 Bn 112.66 Bn 3.81 Bn 128.00
3 Medtronic 103.44 Bn 95.27 Bn 5.76 Bn -361.00
4 Boston Scientific 72.38 Bn 71.17 Bn 3.61 Bn 141.00
5 Edwards Lifesciences 49.76 Bn 46.09 Bn 1.29 Bn 102.00
6 Dexcom 29.53 Bn 28.42 Bn 750.30 Mn 851.00
7 GE HealthCare Technologies 29.51 Bn 27.44 Bn 1.98 Bn -313.00
8 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 241.00
9 Steris 20.69 Bn 20.27 Bn 697.10 Mn 535.00
10 RemSleep Holdings - - -7,636.00 -817,949.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -817,949.00
Sep 30, 2025 -3.01 Mn
Jun 30, 2025 -167,193.00
Dec 31, 2024 1.74 Mn
Sep 30, 2024 134.00
Jun 30, 2024 -69,842.00
Mar 31, 2024 4,338.00
Dec 31, 2023 -1.35 Mn
Sep 30, 2023 -29,951.00
Jun 30, 2023 -8,942.00